Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer

BACKGROUND: Identification of biomarkers associated with benefit of adjuvant chemotherapy in stage II/III colon cancer is an important task. METHODS: Vessel density (VD) and tumour stroma were analysed in a randomised-trial-derived discovery cohort (n = 312) and in a stage II/III group of a populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezheyeuski, Artur, Hrynchyk, Ina, Herrera, Mercedes, Karlberg, Mia, Osterman, Eric, Ragnhammar, Peter, Edler, David, Portyanko, Anna, Ponten, Fredrik, Sjöblom, Tobias, Glimelius, Bengt, Östman, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738077/
https://www.ncbi.nlm.nih.gov/pubmed/31289351
http://dx.doi.org/10.1038/s41416-019-0519-1

Ejemplares similares

Ejemplares similares